Role of Methylation Test Triage in HPV Positive Women

NANot yet recruitingINTERVENTIONAL
Enrollment

10,000

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

February 28, 2026

Conditions
Precancerous Cervical Lesion
Interventions
DIAGNOSTIC_TEST

Methylation Test

"Participants who aged 25-65 years with high-risk HPV infection are recruited.To start with,cervical exfoliated cells are collected, coded (according to the actual enrollment sequence), and stored in the pathology department where methylation testing is performed.In addition,patients will underwent colposcopy and biopsy.~Patients are followed up by cytology, high-risk HPV and methylation tests at 6 and 12 months after enrollment.Cervical conization and hysterectomy will be taken if necessary according to histopathological results. The clinical endpoint is reached when CIN2+ is confirmed by histopathological result."

Trial Locations (1)

200011

Obstetrics and Gynecology Hospital of Fudan University, Shanghai

All Listed Sponsors
collaborator

Peking Union Medical College Hospital

OTHER

collaborator

Chengdu Women's and Children's Central Hospital

OTHER

collaborator

Guangdong Women and Children Hospital

OTHER

collaborator

Second Hospital of Jilin University

OTHER

collaborator

First Affiliated Hospital of Xinjiang Medical University

OTHER

collaborator

Third Affiliated Hospital of Zhengzhou University

OTHER

lead

Obstetrics & Gynecology Hospital of Fudan University

OTHER

NCT06366516 - Role of Methylation Test Triage in HPV Positive Women | Biotech Hunter | Biotech Hunter